Synergy Pharmaceuticals Inc. (SGYP) traded within a range of $6.24 to $6.43 after opening the day at $6.27. The company has seen its stock increase in value by 3.94% so far this year. The stock was up close to 0.48% on light volume in last trading session and closed at $6.33 per share. After the recent gain, the stock is currently holding -11.47% below its 52 week high of $7.15 and 153.2% above its 12-month low of $2.5. The shares are up by over 11.25% in the last three months, and the RSI indicator value of 54.66 is neither bullish nor bearish, tempting investors to stay on the sidelines.
Synergy Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development of drugs to treat gastrointestinal (GI) disorders and diseases. Its lead product candidate is plecanatide, a guanylyl cyclase C receptor agonist that is in Phase III clinical trials to treat chronic idiopathic constipation GI disorders; and for the treatment of constipation-predominant irritable bowel syndrome GI disorders. The company is also developing SP-333, which is in Phase II clinical trials to treat opioid induced constipation, as well as in Phase Ib clinical trials to treat ulcerative colitis. The company has a research collaboration with BIND Therapeutics, Inc. to develop ACCURINS for treatment of a range of cells with novel therapeutic payloads. Synergy Pharmaceuticals Inc. is headquartered in New York, New York.
Sunstone Hotel Investors, Inc. (SHO) continued its upward trend with the stock climbing 0.84% or $0.13 to close the day at $15.56 on active trading volume of 3.21M shares, compared to its three month average trading volume of 2.56M. The Aliso Viejo California 92656 based company has been outperforming the reit – hotel/motel group over the past 52 weeks, with the stock gaining 32.33%, compared to the industry which has advanced 28.42% over the same period. With RSI of 63.89, the stock should still continue to rise and get closer to its one year target estimate of $14.85, making it a hold for now.
Sunstone Hotel Investors, Inc. operates as a real estate investment trust. The firm engages in the acquisition, ownership, asset management, renovation, and sale of luxury, upper upscale, and upscale full-service hotels in the United States. Its portfolio also includes mid-scale hotels. Sunstone Hotel Investors was founded in 1995 and is based in Aliso Viejo, California.
Boyd Gaming Corporation (BYD) gained $0.67 to close the day at a new closing price of $21.33, a 3.24% increase in value from its previous closing price that moved the stock 37.26% above its 52 week low of $15.28. A total of 3.2M shares exchanged hands during the day compared with its three month average trading volume of 1.24M. The stock, which fluctuated between $20.85 and $21.5 during the day, currently situated -1.16% below its 52 week high. The stock is up by 8.88% in the past one month and up by 13.58% over the past three months. With a one year target estimate of $22.77 and RSI of 63.99, the stock still has upside potential, making it a hold for now.
Boyd Gaming Corporation, together with its subsidiaries, operates as a multi-jurisdictional gaming company. It operates in five segments: Las Vegas Locals, Downtown Las Vegas, Midwest and South, Peninsula, and Borgata. The company owns and operates 21 gaming entertainment properties located in Nevada, Illinois, Indiana, Iowa, Kansas, Louisiana, Mississippi, and New Jersey. It also owns and operates a travel agency and a captive insurance company that underwrites travel-related insurance in Hawaii; and the Borgata Hotel Casino & Spa in Atlantic City, New Jersey. As of December 31, 2015, it owned and managed 1,243,007 square feet of casino space comprising 29,736 slot machines, 757 table games, and 11,391 hotel rooms. Boyd Gaming Corporation was founded in 1988 and is headquartered in Las Vegas, Nevada.